| dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
| dc.contributor.author | de la Fuente Vivas, Dalia |
| dc.contributor.author | CAPPITELLI, VINCENZO |
| dc.contributor.author | García Gómez, Rocío |
| dc.contributor.author | Valero Díaz, Sara |
| dc.contributor.author | Amato, Camilla |
| dc.contributor.author | Rodriguez, Javier |
| dc.contributor.author | Duro Sánchez, Santiago |
| dc.contributor.author | Arribas, Joaquin |
| dc.date.accessioned | 2025-03-06T13:36:19Z |
| dc.date.available | 2025-03-06T13:36:19Z |
| dc.date.copyright | 2024 |
| dc.date.issued | 2025-02 |
| dc.identifier.citation | de la Fuente-Vivas D, Cappitelli V, García-Gómez R, Valero-Díaz S, Amato C, Rodriguéz J, et al. ERK1/2 mitogen-activated protein kinase dimerization is essential for the regulation of cell motility. Mol Oncol. 2025 Feb;19(2):452-73. |
| dc.identifier.issn | 1878-0261 |
| dc.identifier.uri | http://hdl.handle.net/11351/12701 |
| dc.description | Quinasas MAP; Motilidad celular; Proteínas de andamiaje |
| dc.language.iso | eng |
| dc.publisher | Wiley |
| dc.relation.ispartofseries | Molecular Oncology;19(2) |
| dc.rights | Attribution 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
| dc.source | Scientia |
| dc.subject | Mama - Càncer - Aspectes genètics |
| dc.subject | Cèl·lules - Motilitat |
| dc.subject | Proteïnes quinases activades per mitògens |
| dc.subject.mesh | Breast Neoplasms |
| dc.subject.mesh | /genetics |
| dc.subject.mesh | Mitogen-Activated Protein Kinase 1 |
| dc.subject.mesh | Cell Movement |
| dc.title | ERK1/2 mitogen-activated protein kinase dimerization is essential for the regulation of cell motility |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.1002/1878-0261.13732 |
| dc.subject.decs | neoplasias de la mama |
| dc.subject.decs | /genética |
| dc.subject.decs | proteína cinasa activada por mitógenos 1 |
| dc.subject.decs | movimiento celular |
| dc.relation.publishversion | https://doi.org/10.1002/1878-0261.13732 |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.organismes | Institut Català de la Salut |
| dc.contributor.authoraffiliation | [de la Fuente-Vivas D, Cappitelli V, Valero-Díaz S, Amato C] Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC), Consejo Superior de Investigaciones Científicas (CSIC) – Universidad de Cantabria, Santander, Spain. [García-Gómez R] Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC), Consejo Superior de Investigaciones Científicas (CSIC) – Universidad de Cantabria, Santander, Spain. Centro de Investigacion Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain. [Rodriguéz J] Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, UK. [Duro-Sánchez S, Arribas J] Centro de Investigacion Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain. Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain. Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Bellaterra, Spain. Preclinical and Translational Research Program, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain |
| dc.identifier.pmid | 39263917 |
| dc.identifier.wos | 001310564500001 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |